SAN FRANCISCO — Don’t let the hype fool you. While the annual JPM Healthcare Conference draws thousands to San Francisco, the deals that drive the biotechnology industry aren’t confined to a single week. Acquisitions, partnerships, and funding rounds happen consistently throughout the year, and the gatherings here are just one piece of the puzzle.
JPM Week Isn’t Everything
The biopharma world descends on San Francisco, but the industry’s momentum isn’t solely dependent on this annual event.
- The JPM Healthcare Conference is a significant event, but it doesn’t dictate the entire year for biotech.
- Deals and collaborations are forged during JPM week, but they also occur regularly throughout the remaining 51 weeks.
- Thousands of industry professionals attend JPM, despite the high cost of accommodations.
It’s a bit of a reality check, honestly. The sheer scale of the JPM Healthcare Conference – the super-sized gathering of the biopharma universe – can feel like everything hinges on the meetings taking place in San Francisco. But the truth is, all the activity that makes biotech “go vroom,” as one observer put it, happens during the other 51 weeks of the year too.
Thousands of industry people descend on the city, willingly enduring overpriced hotel rooms, because this is where a lot of important conversations start. Deals are hatched, partnerships are formed, and funding agreements are finalized. But don’t mistake a concentrated burst of activity for the whole story.
